title: Long-term outcome of patients with idiopathic membranous nephropathy.
abstract: Although idiopathic membranous nephropathy (iMN) is a common glomerular disease, its therapy still remains controversial. The aim of our study was to analyse the outcome of patients with iMN diagnosed and treated in our center. We retrospectively studied 82 patients with iMN that were diagnosed between January 1991 and June 2002. The group consisted of 57 males (69.5%) and 25 females (30.5%) with a mean age of 53 years. The mean follow-up was 56 +/- 38 months. Remission was achieved in 59.2% of patients treated with chlorambucil, 71.4% treated with cyclophosphamide, 85.7% treated with cyclosporine and in 71.4% of those who were left untreated intentionally. However, the proportion of patients in the different treatment subgroups differed significantly (60% vs. 8.5% vs. 8.5% vs. 23%, respectively). The relapse rate was 31.3%. The second-line treatment was effective in a majority of the patients. At the end of follow-up, almost 70% of the patients were in remission with the parameters of nephrotic syndrome significantly improved and renal function unchanged. The renal survival was 100%. Immunosuppressive therapy is effective in iMN, but spontaneous remissions occur as well. Although relapses are frequent, almost 70% of the patients were in remission at the end of follow-up. The renal survival in our group of iMN patients was very good, probably due to preserved renal function at diagnosis.
authors.affiliation: Department of Nephrology of the First Faculty of Medicine, Charles University in Prague, and General Teaching Hospital, Czech Republic. zrihova@centrum.cz
authors.forename: Z
authors.initials: Z
authors.lastname: Ríhová
authors.forename: M
authors.initials: M
authors.lastname: Merta
authors.forename: D
authors.initials: D
authors.lastname: Maixnerová
authors.forename: E
authors.initials: E
authors.lastname: Honsová
authors.forename: J
authors.initials: J
authors.lastname: Reiterová
authors.forename: R
authors.initials: R
authors.lastname: Rysavá
authors.forename: J
authors.initials: J
authors.lastname: Zabka
authors.forename: V
authors.initials: V
authors.lastname: Tesar
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D019233:Retreatment; D015996:Survival Rate